Published on in Vol 7, No 11 (2018): November
Journals
- Strand T, Kives S, Leyland N, Ashkenas J, Janiszewski P, Thiel J. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids. Journal of Obstetrics and Gynaecology Canada 2020;42(12):1475 View
- Bougie O, Bedaiwy M, Laberge P, Lebovic G, Leyland N, Atri M, Murji A. Quality of ultrasonography reporting and factors associated with selection of imaging modality for uterine fibroids in Canada: results from a prospective cohort registry. CMAJ Open 2020;8(3):E506 View
- Murji A, Bedaiwy M, Singh S, Bougie O. Influence of Ethnicity on Clinical Presentation and Quality of Life in Women With Uterine Fibroids: Results From a Prospective Observational Registry. Journal of Obstetrics and Gynaecology Canada 2020;42(6):726 View
- Middelkoop M, de Lange M, Clark T, Mol B, Bet P, Huirne J, Hehenkamp W. Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. Human Reproduction 2022;37(5):884 View
- Chen X, Zhang M, Wang J, Li B, Qin R, Zhang Y, Wan C, Hu R, Zhu J, Zhou B. Post-uterine artery embolization: 3-day MRI changes and their predictive value for therapeutic efficacy in symptomatic uterine fibroids. British Journal of Radiology 2024 View